Reaktion #2469778

ord-33e87df92a314abaa590bfe6d65751a1

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.ADDITIONcontaining
  2. 2
    Sonstigedegassed DME (3 ml) and 2M Na2CO3 (1 ml)
  3. 3
    TemperaturThe resulting mixture is heated
  4. 4
    Sonstigeat 100° C.
  5. 5
    Sonstigefor 45 minutes
  6. 6
    workup.ADDITIONThe reaction mixture is diluted with DCM, MgSO4
  7. 7
    workup.ADDITIONis added
  8. 8
    Filtrationthe mixture is filtered through Celite® (filter agent)
  9. 9
    SonstigeThe filtrate is absorbed onto silica and purification by flash chromatography on silica eluting with MeOH

Vorschrift

N-[2-Chloro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-benzenesulfonamide (Intermediate B) (50 mg, 0.13 mmol), 5-Bromo-4-methyl-pyrimidin-2-ylamine (Intermediate C) (26 mg, 0.14 mmol) and PdCl2(dppf).DCM (10 mg, 0.013 mmol) are placed in a microwave vial containing degassed DME (3 ml) and 2M Na2CO3 (1 ml). The resulting mixture is heated using microwave radiation at 100° C. for 45 minutes. The reaction mixture is diluted with DCM, MgSO4 is added and the mixture is filtered through Celite® (filter agent). The filtrate is absorbed onto silica and purification by flash chromatography on silica eluting with MeOH:DCM (1% to 2% MeOH) affords the title compound.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08263585B2uspto-grants-2012_09